Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Appointed director
Quarterly results
Acq. announced
CC transcript
|
|
HeartWare International, Inc. (HTWR)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/28/2016 |
8-K
| Form 8-K - Current report |
| 05/04/2016 |
8-K
| Form 8-K - Current report |
| 02/25/2016 |
8-K
| Quarterly results |
| 10/29/2015 |
8-K
| Quarterly results |
| 07/30/2015 |
8-K
| Quarterly results |
| 04/30/2015 |
8-K
| Quarterly results |
| 02/26/2015 |
8-K
| Quarterly results |
| 10/30/2014 |
8-K
| Quarterly results |
| 07/31/2014 |
8-K
| Quarterly results |
| 05/01/2014 |
8-K
| Quarterly results |
| 02/27/2014 |
8-K
| Quarterly results |
| 11/07/2013 |
8-K
| Form 8-K - Current report |
| 08/08/2013 |
8-K
| Form 8-K - Current report |
| 04/29/2013 |
8-K
| Quarterly results|
Docs:
|
"HEARTWARE INTERNATIONAL REPORTS $49.2 MILLION IN FIRST QUARTER 2013 REVENUE; 87% INCREASE FROM FIRST QUARTER OF 2012 - U.S. Revenues of $26.2 million, from $6.4 million in First Quarter of 2012; Reflecting First Complete Quarter of Commercialization in U.S. - - Conference call today at 5:00 p.m. U.S. E.T. - Framingham, Mass. and Sydney, Australia, April 29, 2013—HeartWare International, Inc. , a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced revenue of $49.2 million for the first quarter ended March 31, 2013, an 87% increase compared to $26.4 million in revenue for the same period of 2012. “Our results for the first quarter reflect positive initial trends in the commercial l..." |
|
| 02/27/2013 |
8-K
| Form 8-K - Current report |
| 11/09/2012 |
8-K
| Form 8-K - Current report |
| 08/07/2012 |
8-K
| Form 8-K - Current report |
| 05/10/2012 |
8-K
| Form 8-K - Current report |
| 02/16/2012 |
8-K
| Quarterly results|
Docs:
|
"HEARTWARE INTERNATIONAL REPORTS FOURTH QUARTER 2011 REVENUES OF $23.1 MILLION; FULL YEAR 2011 REVENUES OF $82.8 MILLION; 50% INCREASE FROM $55.2 MILLION IN 2010 - Conference call today at 8:00 a.m. U.S. ET - Framingham, Mass. and Sydney, Australia, February 16, 2012—HeartWare International, Inc. , a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, announced revenue of $23.1 million for the fourth quarter ended December 31, 2011, as compared to $20.9 million for the fourth quarter of 2010. For the fiscal year 2011, the Company generated revenues of $82.8 million as compared with $55.2 million in the fiscal year 2010. “Our results for 2011 reflect increasing confidence in the HVAD ® System, as ..." |
|
| 10/27/2011 |
8-K
| Form 8-K - Current report |
| 08/04/2011 |
8-K
| Form 8-K - Current report |
| 05/05/2011 |
8-K
| Form 8-K - Current report |
| 02/24/2011 |
8-K
| Form 8-K - Current report |
| 11/03/2010 |
8-K
| Form 8-K - Current report |
| 08/05/2010 |
8-K
| Form 8-K - Current report |
| 05/03/2010 |
8-K
| Form 8-K - Current report |
| 02/22/2010 |
8-K
| Form 8-K - Current report |
| 11/04/2009 |
8-K
| Quarterly results |
|
|